Treatment Information

Back

Colon Cancer treatment details. Chemotherapy, Biologic therapy.

Vejle Hospital, Vejle, Denmark.

Survival: monthsCountry:Denmark
Toxiciy Grade:3City/State/Province:Vejle
Treatments:Chemotherapy, Biologic therapyHospital:Vejle Hospital
Drugs:Journal:Link
Date:Jun 2013

Description:

Patients:
This phase 2 study involved 64 previously treated patients with KRAS-mutant metastatic colorectal cancer. The median patient age was 62 years and 56% were male.

Treatment:
Patients were treated with the biologic therapy agent temsirolimus (an inhibitor of the mTOR protein that interferes with cancer cell growth) and the chemotherapy agent irinotecan.

Toxicities:
The most severe toxicities were of grade 3 and included infection, fever, and high blood sugar.

Results:
The median overall survival was 5.3 months.

Correspondence: Dr. Karen-Lise G. Spindler; email: [email protected]



Back